… Specifically,(1) M o n i t o r i n g A c t i v i t y = α MA + β MA … n i t o r i n g A c t i v i t y + ω Q
P P S + Ω Q X + λ Q Z Q + ε Q (3) P P S = α PPS + β PPS F i r m V a l u e + ω PPS M o n i t o r i n …

Purpose: To describe the Food and Drug Administration (FDA) review and approval of sunitinib
malate (Sutent). Sunitinib received regular approval for the treatment of gastrointestinal …

Purpose: This report describes the US Food and Drug Administration (FDA) review and
approval of sorafenib (Nexavar, BAY43-9006), a new small-molecule, oral, multi-kinase inhibitor …

We examine firms that reprice their executive stock options and find little evidence that
repricing reflects managerial entrenchment or ineffective governance. Repricing grants are …

Indians have high rates of cardiovascular disease. Hypertension (HTN) is an important
modifiable risk factor. There are no comprehensive reviews or a nationally representative study of …

We study the propensity of firms to commit financial fraud using a sample of SEC enforcement
actions from 2000 to 2006. Controlling for several rm characteristics as well as year and …

This article presents an empirical analysis of the economic performance of the US property-liability
insurance industry, using estimations across 18 lines of insurance for the years 1984 …

We examine the relationship between board monitoring and firm characteristics using a
broad sample of firms over the 8 year period from 1996 to 2003. We find that board …

… flows and a total number of n periods, denoted as L 1 , L 2 , … , L n . The cash flows are due
… In our model, T n is the liquidation date of the firm. Certainly, T n ⩾ T k as the firm should not …

… Results: Patients were randomized in a 2:1 ratio (erlotinib, n = 488 and placebo, n = 243).
Erlotinib was superior to placebo for survival, progression-free survival, and tumor response …